Foqus Technologies is proud to announce that DeepFoqus-Accelerate has received official approval from Health Canada, following its recent FDA 510(k) clearance. With both FDA 510(k) clearance and a Health Canada Medical Device Licence, Foqus is now poised to roll out its groundbreaking solutions to the North American market, delivering uncompromised images at accelerated speeds to shorten MRI scan times.
DeepFoqus-Accelerate addresses a critical need in healthcare systems, particularly in Canada, where the average MRI wait time is 3 to 4 months. By offering a cost-effective software solution, Foqus aims to improve access to timely and high-quality diagnostic imaging in both the U.S. and Canada.
